eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
3/2021
vol. 8
 
Share:
Send email
Share:
abstract:
Special paper

Statement of Polish Respiratory Society and Polish Society of Allergology on the treatment of pulmonary complications in patients after SARS-CoV-2 infection

Wojciech J. Piotrowski
1
,
Adam Barczyk
2
,
Andrzej Chciałowski
3
,
Joanna Chorostowska-Wynimko
4
,
Małgorzata Czajkowska-Malinowska
5
,
Aleksander Kania
6
,
Maciej Kupczyk
7
,
Krzysztof Sładek
6
,
Marek Kulus
8
,
Paweł Śliwiński
9

1.
Klinika Pneumonologii, I Katedra Chorób Wewnętrznych, Uniwersytet Medyczny, Łódź, Polska
2.
Katedra i Klinika Pneumonologii, Śląski Uniwersytet Medyczny, Katowice, Polska
3.
Klinika Chorób Infekcyjnych i Alergologii, Wojskowy Instytut Medyczny, Warszawa, Polska
4.
Zakład Genetyki i Immunologii Klinicznej, Instytut Gruźlicy i Chorób Płuc, Warszawa, Polska
5.
Kujawsko-Pomorskie Centrum Pulmonologii, Bydgoszcz, Polska
6.
Klinika Pulmonologii, II Katedra Chorób Wewnętrznych im. Prof. A. Szczeklika, Oddział Kliniczny Pulmonologii i Alergologii Szpitala Uniwersyteckiego w Krakowie, Wydział Lekarski, Uniwersytet Jagielloński Collegium Medicum, Kraków, Polska
7.
Klinika Chorób Wewnętrznych, Astmy i Alergii, Uniwersytet Medyczny, Łódź, Polska
8.
Klinika Pneumonologii i Alergologii Wieku Dziecięcego, Warszawski Uniwersytet Medyczny, Warszawa, Polska
9.
II Klinika Chorób Płuc, Instytut Gruźlicy i Chorób Płuc, Warszawa, Polska
Alergologia Polska – Polish Journal of Allergology 2021; 8, 3: 101–129
DOI: https://doi.org/10.5114/pja.2021.109379
Online publish date: 2021/09/24
View full text Get citation
 
PlumX metrics:
The aim of this document is to provide physicians treating patients with a history of COVID-19 pneumonia with recommendations on proper diagnostics and management of respiratory sequelae associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The expert panel provides 32 recommendations with respect to the treatment of lung consequences (including antibiotic therapy, corticosteroid therapy, and antithrombotic prophylaxis and treatment), pulmonary rehabilitation, lung transplantation, patient monitoring, and ambulatory settings. The management of patients with respiratory comorbidities (asthma, chronic obstructive pulmonary disease, lung cancer, and interstitial lung disease) and the medications used for treatment of these conditions, such as corticosteroids and antifibrotic drugs, is discussed. Presented recommendations are based on the most recent reports and aimed at providing patients post-COVID-19 respiratory sequelae with optimal standards of care.
keywords:

SARS-CoV-2 pandemic, COVID-19, respiratory sequelae, consensus



Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.